Albert Ya-Po Wu, MD, PHD
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wu’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C150144 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · University of Washington School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$247,785
Medicare paid this office $247,785 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 66 | $40,425 | $586 |
| Removal of up to 1/4 of eyelid margin and repair of eyelid | 73 | $28,005 | $298 |
| Long return visit (40+ min) | 189 | $27,448 | $125 |
| Reconstruction of eyelid margin | 58 | $17,340 | $294 |
| New patient visit (60+ min) | 69 | $10,647 | $154 |
See all 14 services
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 66 | $40,425 | $586 |
| Removal of up to 1/4 of eyelid margin and repair of eyelid | 73 | $28,005 | $298 |
| Long return visit (40+ min) | 189 | $27,448 | $125 |
| Reconstruction of eyelid margin | 58 | $17,340 | $294 |
| New patient visit (60+ min) | 69 | $10,647 | $154 |
| Correction of widely-opened upper eyelid | 19 | $8,355 | $440 |
| Release of scar tissue from conjunctiva | 27 | $7,532 | $269 |
| Plastic repair of tear duct | 12 | $7,022 | $540 |
| Insertion of probe into nasal tear duct | 32 | $4,818 | $146 |
| Suture repair of turning-outward upper or lower eyelid defect | 11 | $2,284 | $208 |
| Exam of visual field with extended testing | 91 | $2,194 | $24 |
| Removal of growth of eyelid | 11 | $1,405 | $78 |
| Photography of content of eyes | 141 | $373 | $3 |
| Telephone medical discussion provided by nonphysician professional, 11-20 minutes | 15 | $297 | $20 |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 21% · Women 59% · Also on Medicaid 36% · Health risk score 1.22. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 73% · Diabetes 32% · Coronary heart disease 25% · Depression 20% · Chronic kidney disease 17% · Atrial fibrillation 16% · Heart failure 15% · Cancer 14% · Stroke 10% · COPD 6% · Dementia 6%.
The office billed $2,892,860, Medicare allowed $315,362 and paid $247,785; for 1,114 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 1,114 | 76 | 1.22 | $2,892,860 | $247,785 |
| 2023 | 76 | 184 | 77 | 1.24 | $255,455 | $31,540 |
| 2022 | 182 | 529 | 73 | 1.30 | $1,279,560 | $106,468 |
| 2021 | 162 | 451 | 75 | 1.11 | $741,702 | $70,703 |
| 2020 | 66 | 185 | 74 | 1.43 | $363,817 | $26,699 |
| 2019 | 61 | 220 | 73 | 1.37 | $307,718 | $30,238 |
| 2018 | 42 | 155 | 74 | 1.57 | $268,904 | $21,330 |
| 2017 | 112 | 963 | 73 | 1.88 | $680,522 | $104,214 |
| 2016 | 120 | 1,261 | 74 | 1.57 | $797,315 | $145,063 |
| 2015 | 123 | 1,407 | 72 | 1.55 | $556,108 | $108,580 |
| 2014 | 109 | 527 | 72 | 1.64 | $306,317 | $60,037 |
| 2013 | 72 | 260 | 71 | 1.72 | $168,507 | $39,235 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 41 | $5,328 | $124 |
| New patient visit (60+ min) | 29 | $4,732 | $163 |
| Exam of visual field with extended testing | 12 | $302 | $25 |
| Photography of content of eyes | 34 | $91 | $3 |
2022: 8 services
| Long return visit (40+ min) | 118 | $14,358 | $113 |
| Removal of up to 1/4 of eyelid margin and repair of eyelid | 25 | $11,304 | $390 |
| New patient visit (60+ min) | 49 | $7,462 | $152 |
| Reconstruction of eyelid margin | 13 | $4,061 | $312 |
| Reconstruction of eyelid margin | 11 | $3,400 | $309 |
| Insertion of probe into nasal tear duct | 21 | $3,135 | $149 |
| Exam of visual field with extended testing | 35 | $731 | $20 |
| Photography of content of eyes | 84 | $223 | $3 |
2021: 9 services
| New patient visit (60+ min) | 66 | $11,167 | $169 |
| Long return visit (40+ min) | 64 | $8,469 | $125 |
| Removal of up to 1/4 of eyelid margin and repair of eyelid | 17 | $7,448 | $414 |
| Reconstruction of eyelid margin | 11 | $5,213 | $474 |
| Insertion of probe into nasal tear duct | 27 | $4,484 | $166 |
| Return visit (30+ min) | 23 | $2,212 | $79 |
| New patient visit (45+ min) | 18 | $2,063 | $115 |
| Exam of visual field with extended testing | 24 | $543 | $23 |
| Photography of content of eyes | 77 | $216 | $3 |
2020: 4 services
| New patient visit (45+ min) | 20 | $2,330 | $116 |
| Return visit (30+ min) | 25 | $1,839 | $71 |
| Long return visit (40+ min) | 11 | $1,008 | $92 |
| Photography of content of eyes | 34 | $90 | $3 |
2019: 4 services
| New patient visit (45+ min) | 21 | $2,183 | $104 |
| Long return visit (40+ min) | 18 | $1,737 | $96 |
| Return visit (30+ min) | 16 | $1,344 | $71 |
| Photography of content of eyes | 50 | $201 | $3 |
2018: 4 services
| Insertion of probe into nasal tear duct | 14 | $2,019 | $144 |
| Long return visit (40+ min) | 16 | $1,596 | $100 |
| New patient visit (45+ min) | 12 | $1,381 | $115 |
| Photography of content of eyes | 37 | $153 | $3 |
2017: 13 services
| Muscle flap wound repair at head and neck | 15 | $22,095 | $1,105 |
| Insertion of probe into nasal tear duct | 71 | $21,001 | $184 |
| Established patient complete exam of visual system | 59 | $7,723 | $100 |
| Extensive repair of turning-outward eyelid defect | 16 | $6,312 | $332 |
| Release of scar tissue from conjunctiva | 16 | $6,086 | $380 |
| Plastic repair of tear duct | 12 | $4,516 | $347 |
| Photography of content of eyes | 109 | $2,910 | $17 |
| New patient visit (45+ min) | 24 | $2,900 | $121 |
| Examination of eye by ophthalmoscope with retinal drawing | 49 | $2,216 | $39 |
| Return visit (30+ min) | 18 | $1,420 | $79 |
| Established patient problem focused exam of visual system | 17 | $1,396 | $73 |
| Exam of visual field with extended testing | 14 | $717 | $51 |
| Imaging of optic nerve | 15 | $424 | $28 |
2016: 11 services
| Insertion of probe into nasal tear duct | 90 | $34,007 | $214 |
| Release of scar tissue from conjunctiva | 34 | $15,547 | $420 |
| Removal of over 1/4 of eyelid margin and repair of eyelid | 17 | $10,283 | $571 |
| Established patient problem focused exam of visual system | 74 | $9,916 | $73 |
| Extensive repair of turning-outward eyelid defect | 27 | $9,420 | $325 |
| Repair of tendon of upper eyelid | 12 | $8,448 | $704 |
| Established patient complete exam of visual system | 47 | $5,820 | $108 |
| Photography of content of eyes | 115 | $4,140 | $18 |
| New patient visit (45+ min) | 14 | $2,070 | $148 |
| Exam of visual field with extended testing | 24 | $1,445 | $58 |
| Examination of eye by ophthalmoscope with retinal drawing | 26 | $1,169 | $43 |
2015: 8 services
| Insertion of probe into nasal tear duct | 63 | $29,663 | $291 |
| Established patient problem focused exam of visual system | 61 | $8,833 | $74 |
| Removal of over 1/4 of eyelid margin and repair of eyelid | 11 | $7,875 | $606 |
| Extensive repair of turning-outward eyelid defect | 12 | $6,201 | $517 |
| New patient visit (45+ min) | 40 | $5,558 | $139 |
| Photography of content of eyes | 109 | $3,580 | $19 |
| Examination of eye by ophthalmoscope with retinal drawing | 44 | $2,102 | $47 |
| Exam of visual field with intermediate testing | 13 | $563 | $43 |
2014: 7 services
| Insertion of probe into nasal tear duct | 16 | $4,233 | $235 |
| Established patient problem focused exam of visual system | 42 | $4,145 | $68 |
| New patient visit (45+ min) | 25 | $3,303 | $132 |
| Photography of content of eyes | 88 | $2,374 | $18 |
| Established patient complete exam of visual system | 14 | $1,452 | $97 |
| Examination of eye by ophthalmoscope with retinal drawing | 22 | $1,036 | $37 |
| Return visit (30+ min) | 11 | $949 | $86 |
2013: 3 services
| Established patient problem focused exam of visual system | 47 | $5,720 | $71 |
| Established patient complete exam of visual system | 12 | $1,234 | $103 |
| Photography of content of eyes | 38 | $1,118 | $18 |
Medicaid work
$5,668 in 2024
Medicaid paid $5,668 for 117 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 76 | $5,179 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 41 | $489 |
| 2024 | 117 | 2 | 22 | $5,668 |
| 2022 | 52 | 2 | 23 | $4,016 |
| 2021 | 13 | 1 | 13 | $1,678 |
See the largest Medicaid services in earlier years
2022
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 29 | $3,354 |
| Long return visit (40+ min) | 23 | $662 |
2021
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 13 | $1,678 |
Drugs they prescribed that Part D paid
$1,474
Pharmacies billed $1,474 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 14% of their Part D prescriptions (16 of 114) in 2024. A higher opioid share than 9 in 10 peers; the typical ophthalmology clinician is at 0%.
67 generic and 47 brand-name prescriptions · $1,474 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Neomycin-Polymyxin-Dexameth | 46 | $590 | $9 |
| Hydrocodone-Acetaminophen | 12 | $52 | $4 |
Year by year
| 2024 | 114 | 57 | 14% (16) | 41% | $1,474 |
| 2023 | 11 | None | 0% (0) | None | $203 |
| 2022 | 48 | 26 | 23% (11) | 38% | $578 |
| 2021 | 57 | 34 | 25% (14) | 51% | $661 |
| 2020 | 17 | None | None | None | $415 |
| 2019 | 22 | 11 | 0% (0) | 64% | $531 |
| 2018 | 20 | None | None | None | $1,795 |
| 2017 | 81 | 30 | None | 35% | $9,366 |
| 2016 | 122 | 50 | None | 41% | $11,904 |
| 2015 | 144 | 43 | None | 45% | $15,491 |
| 2014 | 105 | 37 | 13% (14) | 41% | $13,439 |
| 2013 | 58 | 19 | None | 26% | $4,518 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Neomycin-Polymyxin-Dexameth | 30 | $409 | $14 |
2021: 2 drugs
| Neomycin-Polymyxin-Dexameth | 32 | $428 | $13 |
| Hydrocodone-Acetaminophen | 13 | $96 | $7 |
2019: 1 drug
| Neomycin-Polymyxin-Dexameth | 12 | $166 | $14 |
2017: 2 drugs
| Bacitracin | 13 | $1,976 | $152 |
| Neomycin-Polymyxin-Dexameth | 20 | $338 | $17 |
2016: 2 drugs
| Bacitracin | 27 | $3,258 | $121 |
| Latanoprost | 14 | $149 | $11 |
2015: 3 drugs
| Tobramycin-Dexamethasone | 17 | $1,707 | $100 |
| Bacitracin | 11 | $936 | $85 |
| Prednisolone Acetate | 14 | $576 | $41 |
2014: 3 drugs
| Tobradex | 22 | $7,177 | $326 |
| Bacitracin | 14 | $1,204 | $86 |
| Tobramycin-Dexamethasone | 15 | $1,090 | $73 |
2013: 2 drugs
| Bacitracin | 17 | $1,359 | $80 |
| Tobramycin-Dexamethasone | 12 | $1,075 | $90 |
Money from drug and device companies
$189 in 2025
| 2025 | 4 | 4 | None | $189 |
| 2022 | 2 | 7 | $2,400 | $2,810 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $71 | 1 payment
|
| Amgen | Tepezza | $70 | 1 payment
|
| Alcon Vision | Clareon Panoptix Pro | $33 | 1 payment
|
| Abbvie | Botox | $15 | 1 payment
|
See all 4 published payments
| Alcon Vision | Meals · 2025-12-18 | Clareon Panoptix Pro | $33 |
| Biotissue Holdings | Meals · 2025-06-04 | None | $71 |
| Amgen | Meals · 2025-04-02 | Tepezza | $70 |
| Abbvie | Meals · 2025-03-05 | Botox | $15 |
See earlier years (2022)
2022: $2,810
| Horizon Therapeutics plc | Tepezza | $2,778 | 5 payments
|
| Alcon Vision | Dailies Total1 Multifocal | $32 | 2 payments
|
Professional record
- NPI
- 1790945046
- Licence
- CA C150144, NY 262966California C150144: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-06-10
- NPI last updated
- 2025-03-11
- NPI record certified
- 2025-03-11
This is when the NPI record was last certified, not a medical board exam.